Patient Square Capital’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
GS
SCM
WP
Patient Square Capital's RCUS Position: Q2 2026 in Review
Patient Square Capital increased its Arcus Biosciences (RCUS) stake by 82% in Q2 2026, buying an estimated $3.97M and bringing the position to 355,800 shares worth $11M. The position accounts for 1.7% of the portfolio, ranked #14.
Patient Square Capital first reported a position in RCUS in Q4 2025 and has held it in 3 quarters since. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.
- Patient Square Capital held 355,800 shares of Arcus Biosciences worth $11M as of Q2 2026.
- Patient Square Capital bought 160,800 Arcus Biosciences shares in Q2 2026, an estimated $3.97M.
- Arcus Biosciences made up 1.7% of Patient Square Capital's portfolio in Q2 2026, its #14 holding.
- Patient Square Capital first reported a position in Arcus Biosciences in Q4 2025 and has held it in 3 quarters since.
- 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.
Based on Patient Square Capital's 13F filing for Q2 2026, filed 12 Aug 2026.